Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Riluzole neuroprotection in a parkinson's disease model involves suppression of reactive astrocytosis but not GLT-1 regulation'. Together they form a unique fingerprint.

Medicine and Dentistry

Neuroscience